|FDA approves Vertex's Hep C drug|
|By Staff and Wire Reports|
|Monday, 23 May 2011 18:22|
Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today announced that the FDA approved INCIVEK (telaprevir) tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease (some level of damage to the liver but the liver still functions), including cirrhosis (scarring of the liver). The drug was approved for both people who are new to treatment as well as for people who were treated previously but who did not achieve a viral cure (relapsers, partial responders and null responders).
“Hepatitis C can lead to liver failure, cancer and the need for a transplant, and for the past decade, the best we could offer patients was a year of difficult treatment that resulted in a viral cure for fewer than half of them,” said Ira Jacobson, M.D., Chief of the Division of Gastroenterology and Hepatology, Weill Cornell Medical College and principal investigator for a Phase 3 study of INCIVEK. “With INCIVEK, 79 percent of people new to treatment achieved a viral cure.” Earlier this month the FDA also approved Merck's Hep C drug Victrelis, marking the first new breakthrough treatments for liver disease to gain approval in the past 20 years.
The company said a 12-week course of treatment will cost $49,200 which compares to $30,000 for standard therapies. The drug is expected to reach block bluster status with annual sales in the billions.
Shares of Vertex gained 81 cents to $55.81.
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) is pleased to provide an update on its ongoing Phase I clinical trial to evaluate ANAVEX 2-73, the company's lead candidate for Alzheimer's disease.
BioElectronics Corporation (PINKSHEETS: BIEL) (OTCQB: BIEL), the maker of inexpensive, disposable drug-free topical pain devices, today announced that they have filed a Provisional Patent application, "RF Induced Thermal Treatment for Tissue Pain," and have received Issue Notification from the U. S. Patent and Trademark Office that they expect to issue a design patent for the Company's back belt.
BioDrain Medical, Inc. (OTC Bulletin Board:BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, announced today the Canadian Intellectual Property Office has issued patent – Number 2,495,747 – for the Company's Streamway System "for disposing of liquid surgical waste for protection of healthcare workers."
BioTech Medics, Inc., (PINKSHEETS: BMCS) announced today that it is being represented at the 10th anniversary of ILSI-BioMed Israel Week by MicroCap Review Magazine. ISLI-BioMed is the largest life science convention outside the USA. More than 1,000 are registered to attend.
Connectyx Technologies Holdings Group, Inc. (PINKSHEETS: CTYX) ("Connectyx"), www.connectyx.com, manufacturer and distributor of the MedFlash®, the nation's premier Personal Health and Wellness Management System (ePHM) for maintaining personal health records (PHR), announced today it has partnered with 1-800-DOCTORS to provide the most widely accepted commercial PHR to the physician community and the pharmaceutical industry.
DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the Company's selection as a 2011 Crain's Leading EDGE award winner for the second consecutive year.
Diversified Global Holdings Group Inc. (OTCQB: DGHG) today announced that it has successfully completed the acquisition of Banyan Development LLC.
Eli Lilly and Company (NYSE:LLY) today announced that it has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a newly-formed and privately-held biotechnology company.
Genesis Biopharma, Inc. (OTC.BB:GNBP), a biotechnology company developing targeted cancer therapies, today announced that former California Governor, Gray Davis, has joined the company as Chairman of its Corporate Advisory Board. Governor Davis is committed to the improvement of healthcare and advancement of medical technologies.
General Cannabis, Inc. (PINKSHEETS: CANA), a technology-based Internet marketing services company, today reported financial results for the first quarter ending March 31, 2011.
Given Imaging Ltd. (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced clearance from the U.S. Food and Drug Administration (FDA) for the PillCam® ESO 3 video capsule for visualizing esophageal mucosa.
Healthnostics, Inc. (PINKSHEETS: HNSS) paid $280,994 to eliminate notes payable, leaving a balance of $51,463 which will be retired in the coming months.
Microholdings US (MCHU) (PINKSHEETS: MCHU) announced today that they will start advertising The Edge Pain Chips in a National TV campaign with Charter Media.
PAREXEL International Corporation (NASDAQ:PRXL) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in Palos Verdes, CA. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at 4:00 p.m. PT on Wednesday, June 8, 2011.
Pacira Pharmaceuticals, Inc., (Nasdaq:PCRX), an emerging specialty pharmaceutical company, today announced that clinical data highlighting the safety profile of EXPAREL™ (bupivacaine extended-release liposome injection) will be presented at the 2011 International Anesthesia Research Society (IARS) Annual Meeting in Vancouver, British Columbia.
PROLOR Biotech, Inc. (NYSE Amex:PBTH), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that its proprietary CTP and Reversible PEGylation platforms for extending the longevity of most proteins, peptides and small molecules will be highlighted today in a presentation at the joint meeting of the Summer Neuropeptide Conference and The European Neuropeptide Club (ENC).
PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company ("Proteonomix" or the "Company") focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to announce the results of animal studies involving the Company's UMK-121 technology.
Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that data from several studies demonstrating the clinical utility of the Company's miRview® products to identify and classify a variety of cancers will be presented at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting taking place at the McCormick Place Convention Center in Chicago from June 3-7, 2011.
Sangamo BioSciences, Inc. (Nasdaq:SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein (ZFP) Therapeutics® were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). The meeting was held in Seattle from May 18-21, 2011.
Sigma-Aldrich Corporation (Nasdaq:SIAL) announced today it has acquired all outstanding shares of Vetec Quimica Fina Ltda to strengthen the Company's position in Latin America. Based in Brazil, Vetec is a leading supplier of high quality specialty chemicals for the academic and industrial markets and provides products that support research, development and manufacturing.
Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a holding company providing healthcare services, staffing and durable medical equipment to medical institutions, has previously announced the intent to merge with a network of medical clinics based in the Washington, DC area.
Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced that William A. Mathies, the company's chairman and chief executive officer, and L. Bryan Shaul, the company's chief financial officer, will present at the Jefferies Global Healthcare Conference on Tuesday, June 7, at 10 a.m. Eastern.
SureQuest Systems, Inc. (PINKSHEETS: SUQU), a leading provider of dining management software solutions for the food service industry, is pleased to announce that it has been selected as the Dining Management System for Unidine Corporation of Newton, MA.
TRIMEDYNE, INC. (OTCBB: TMED) today reported its financial results for the quarter ended March 31, 2011.